-
1
-
-
0035811625
-
Hepatitis C virus infection
-
COI: 1:STN:280:DC%2BD3MzosFGrug%3D%3D, PID: 11439948
-
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52. https://doi.org/10.1056/NEJM200107053450107.
-
(2001)
N Engl J Med
, vol.345
, Issue.1
, pp. 41-52
-
-
Lauer, G.M.1
Walker, B.D.2
-
2
-
-
84900339263
-
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
-
PID: 24725239
-
Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370(20):1889–98. https://doi.org/10.1056/NEJMoa1402454.
-
(2014)
N Engl J Med
, vol.370
, Issue.20
, pp. 1889-1898
-
-
Afdhal, N.1
Zeuzem, S.2
Kwo, P.3
Chojkier, M.4
Gitlin, N.5
Puoti, M.6
Romero-Gomez, M.7
Zarski, J.P.8
Agarwal, K.9
Buggisch, P.10
Foster, G.R.11
Bräu, N.12
Buti, M.13
Jacobson, I.M.14
Subramanian, G.M.15
Ding, X.16
Mo, H.17
Yang, J.C.18
Pang, P.S.19
Symonds, W.T.20
McHutchison, J.21
Muir, A.J.22
Mangia, A.23
Marcellin, P.24
more..
-
3
-
-
84899068302
-
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin
-
COI: 1:CAS:528:DC%2BC2cXnt1Grsrg%3D, PID: 24720703
-
Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, et al. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med. 2014;370(17):1594–603. https://doi.org/10.1056/NEJMoa1315722.
-
(2014)
N Engl J Med
, vol.370
, Issue.17
, pp. 1594-1603
-
-
Feld, J.J.1
Kowdley, K.V.2
Coakley, E.3
Sigal, S.4
Nelson, D.R.5
Crawford, D.6
Weiland, O.7
Aguilar, H.8
Xiong, J.9
Pilot-Matias, T.10
DaSilva-Tillmann, B.11
Larsen, L.12
Podsadecki, T.13
Bernstein, B.14
-
4
-
-
84931569160
-
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
-
COI: 1:CAS:528:DC%2BC2MXls1Grt7k%3D, PID: 25837829
-
Hezode C, Asselah T, Reddy KR, Hassanein T, Berenguer M, Fleischer-Stepniewska K, et al. Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial. Lancet. 2015;385:2502–9. https://doi.org/10.1016/S0140-6736(15)60159-3.
-
(2015)
Lancet
, vol.385
, pp. 2502-2509
-
-
Hezode, C.1
Asselah, T.2
Reddy, K.R.3
Hassanein, T.4
Berenguer, M.5
Fleischer-Stepniewska, K.6
-
5
-
-
84925423399
-
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
-
COI: 1:CAS:528:DC%2BC2cXhvFSgtr3N, PID: 25467560
-
Sulkowski M, Hezode C, Gerstoft J, Vierling JM, Mallolas J, Pol S, et al. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial. Lancet. 2015;385(9973):1087–97. https://doi.org/10.1016/S0140-6736(14)61793-1.
-
(2015)
Lancet
, vol.385
, Issue.9973
, pp. 1087-1097
-
-
Sulkowski, M.1
Hezode, C.2
Gerstoft, J.3
Vierling, J.M.4
Mallolas, J.5
Pol, S.6
Kugelmas, M.7
Murillo, A.8
Weis, N.9
Nahass, R.10
Shibolet, O.11
Serfaty, L.12
Bourliere, M.13
DeJesus, E.14
Zuckerman, E.15
Dutko, F.16
Shaughnessy, M.17
Hwang, P.18
Howe, A.Y.M.19
Wahl, J.20
Robertson, M.21
Barr, E.22
Haber, B.23
more..
-
6
-
-
85020554808
-
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection
-
COI: 1:CAS:528:DC%2BC2sXhtF2qs7jP, PID: 27997679
-
Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K, et al. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection. Hepatology. 2017;66(2):371–8. https://doi.org/10.1002/hep.28995.
-
(2017)
Hepatology
, vol.66
, Issue.2
, pp. 371-378
-
-
Balistreri, W.F.1
Murray, K.F.2
Rosenthal, P.3
Bansal, S.4
Lin, C.H.5
Kersey, K.6
Massetto, B.7
Zhu, Y.8
Kanwar, B.9
German, P.10
Svarovskaia, E.11
Brainard, D.M.12
Wen, J.13
Gonzalez-Peralta, R.P.14
Jonas, M.M.15
Schwarz, K.16
-
7
-
-
85027407746
-
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
-
COI: 1:CAS:528:DC%2BC2sXhtlegsLrO, PID: 28818546
-
Forns X, Lee SS, Valdes J, Lens S, Ghalib R, Aguilar H, et al. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. Lancet Infect Dis. 2017;17:1062–8. https://doi.org/10.1016/S1473-3099(17)30496-6.
-
(2017)
Lancet Infect Dis
, vol.17
, pp. 1062-1068
-
-
Forns, X.1
Lee, S.S.2
Valdes, J.3
Lens, S.4
Ghalib, R.5
Aguilar, H.6
Felizarta, F.7
Hassanein, T.8
Hinrichsen, H.9
Rincon, D.10
Morillas, R.11
Zeuzem, S.12
Horsmans, Y.13
Nelson, D.R.14
Yu, Y.15
Krishnan, P.16
Lin, C.W.17
Kort, J.J.18
Mensa, F.J.19
-
8
-
-
85019575184
-
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
-
COI: 1:CAS:528:DC%2BC2sXntFeks70%3D, PID: 28412293
-
Kwo PY, Poordad F, Asatryan A, Wang S, Wyles DL, Hassanein T, et al. Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis. J Hepatol. 2017;67(2):263–71. https://doi.org/10.1016/j.jhep.2017.03.039.
-
(2017)
J Hepatol
, vol.67
, Issue.2
, pp. 263-271
-
-
Kwo, P.Y.1
Poordad, F.2
Asatryan, A.3
Wang, S.4
Wyles, D.L.5
Hassanein, T.6
Felizarta, F.7
Sulkowski, M.S.8
Gane, E.9
Maliakkal, B.10
Overcash, J.S.11
Gordon, S.C.12
Muir, A.J.13
Aguilar, H.14
Agarwal, K.15
Dore, G.J.16
Lin, C.W.17
Liu, R.18
Lovell, S.S.19
Ng, T.I.20
Kort, J.21
Mensa, F.J.22
more..
-
9
-
-
45649083859
-
Pregnancy complications associated with hepatitis C: data from a 2003–2005 Washington state birth cohort
-
PID: 18486089, e1–9
-
Pergam SA, Wang CC, Gardella CM, Sandison TG, Phipps WT, Hawes SE. Pregnancy complications associated with hepatitis C: data from a 2003–2005 Washington state birth cohort. Am J Obstet Gynecol. 2008;199(1):38 e1–9. https://doi.org/10.1016/j.ajog.2008.03.052.
-
(2008)
Am J Obstet Gynecol
, vol.199
, Issue.1
, pp. 38
-
-
Pergam, S.A.1
Wang, C.C.2
Gardella, C.M.3
Sandison, T.G.4
Phipps, W.T.5
Hawes, S.E.6
-
10
-
-
84951077638
-
Outcomes of pregnancies complicated by liver cirrhosis, portal hypertension, or esophageal varices
-
Puljic A, Salati J, Doss A, Caughey AB. Outcomes of pregnancies complicated by liver cirrhosis, portal hypertension, or esophageal varices. J Matern Fetal Neona. 2016;29(3):506–9. https://doi.org/10.3109/14767058.2015.1009438.
-
(2016)
J Matern Fetal Neona
, vol.29
, Issue.3
, pp. 506-509
-
-
Puljic, A.1
Salati, J.2
Doss, A.3
Caughey, A.B.4
-
11
-
-
0035215055
-
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study
-
COI: 1:CAS:528:DC%2BD38XjsVClu7o%3D, PID: 11740231
-
Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, et al. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr. 2001;33(5):570–5.
-
(2001)
J Pediatr Gastroenterol Nutr
, vol.33
, Issue.5
, pp. 570-575
-
-
Ceci, O.1
Margiotta, M.2
Marello, F.3
Francavilla, R.4
Loizzi, P.5
Francavilla, A.6
Mautone, A.7
Impedovo, L.8
Ierardi, E.9
Mastroianni, M.10
Bettocchi, S.11
Selvaggi, L.12
-
12
-
-
27944481200
-
Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy
-
PID: 16267758
-
Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192(11):1880–9. https://doi.org/10.1086/497701.
-
(2005)
J Infect Dis
, vol.192
, Issue.11
, pp. 1880-1889
-
-
Mast, E.E.1
Hwang, L.Y.2
Seto, D.S.3
Nolte, F.S.4
Nainan, O.V.5
Wurtzel, H.6
-
13
-
-
66449137382
-
Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages
-
COI: 1:CAS:528:DC%2BD1MXmtVWisLs%3D, PID: 19382251
-
Shebl FM, El-Kamary SS, Saleh DA, Abdel-Hamid M, Mikhail N, Allam A, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol. 2009;81(6):1024–31. https://doi.org/10.1002/jmv.21480.
-
(2009)
J Med Virol
, vol.81
, Issue.6
, pp. 1024-1031
-
-
Shebl, F.M.1
El-Kamary, S.S.2
Saleh, D.A.3
Abdel-Hamid, M.4
Mikhail, N.5
Allam, A.6
-
14
-
-
84978328536
-
Hepatitis C virus (HCV) vertical transmission in 12-month-old infants born to HCV-infected women and assessment of maternal risk factors
-
PID: 26180831
-
Jhaveri R, Hashem M, El-Kamary SS, Saleh DA, Sharaf S, El-Mougy F, et al. Hepatitis C virus (HCV) vertical transmission in 12-month-old infants born to HCV-infected women and assessment of maternal risk factors. Open Forum Infect Dis. 2015;2(2):ofv089. https://doi.org/10.1093/ofid/ofv089.
-
(2015)
Open Forum Infect Dis
, vol.2
, Issue.2
, pp. ofv089
-
-
Jhaveri, R.1
Hashem, M.2
El-Kamary, S.S.3
Saleh, D.A.4
Sharaf, S.5
El-Mougy, F.6
-
15
-
-
17344364927
-
Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and infants transmission study
-
COI: 1:STN:280:DyaK1c3mvVyguw%3D%3D, PID: 9607823
-
Thomas DL, Villano SA, Riester KA, Hershow R, Mofenson LM, Landesman SH, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and infants transmission study. J Infect Dis. 1998;177(6):1480–8.
-
(1998)
J Infect Dis
, vol.177
, Issue.6
, pp. 1480-1488
-
-
Thomas, D.L.1
Villano, S.A.2
Riester, K.A.3
Hershow, R.4
Mofenson, L.M.5
Landesman, S.H.6
Hollinger, F.B.7
Davenny, K.8
Riley, L.9
Diaz, C.10
Tang, H.B.11
Quinn, T.C.12
-
16
-
-
84949130701
-
Mother-to-child transmission of hepatitis C virus (HCV) among HIV/HCV-coinfected women
-
Checa Cabot CA, Stoszek SK, Quarleri J, Losso MH, Ivalo S, Peixoto MF, et al. Mother-to-child transmission of hepatitis C virus (HCV) among HIV/HCV-coinfected women. J Pediatr Infect Dis Soc. 2013;2(2):126–35. https://doi.org/10.1093/jpids/pis091.
-
(2013)
J Pediatr Infect Dis Soc
, vol.2
, Issue.2
, pp. 126-135
-
-
Checa Cabot, C.A.1
Stoszek, S.K.2
Quarleri, J.3
Losso, M.H.4
Ivalo, S.5
Peixoto, M.F.6
Pilotto, J.H.7
Salomon, H.8
Sidi, L.C.9
Read, J.S.10
-
17
-
-
84922431738
-
Hepatitis C virus in pregnancy and early childhood: current understanding and knowledge deficits
-
Jhaveri R, Swamy GK. Hepatitis C virus in pregnancy and early childhood: current understanding and knowledge deficits. J Pediatr Infect Dis Soc. 2014;3(Suppl 1):S13–8. https://doi.org/10.1093/jpids/piu045.
-
(2014)
J Pediatr Infect Dis Soc
, vol.3
, pp. S13-S18
-
-
Jhaveri, R.1
Swamy, G.K.2
-
18
-
-
0033064846
-
Spontaneous recovery from perinatal infection due to hepatitis C virus
-
COI: 1:STN:280:DyaK1M7lt1CisA%3D%3D, PID: 10028086
-
Padula D, Rodella A, Spandrio M, Rossini A, Cariani E. Spontaneous recovery from perinatal infection due to hepatitis C virus. Clin Infect Dis. 1999;28(1):141–2.
-
(1999)
Clin Infect Dis
, vol.28
, Issue.1
, pp. 141-142
-
-
Padula, D.1
Rodella, A.2
Spandrio, M.3
Rossini, A.4
Cariani, E.5
-
19
-
-
20844433736
-
Three broad modalities in the natural history of vertically acquired hepatitis C virus infection
-
European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis. 2005;41(1):45–51.
-
(2005)
Clin Infect Dis
, vol.41
, Issue.1
, pp. 45-51
-
-
-
20
-
-
0036829559
-
Children with hepatitis C
-
PID: 12407591
-
Jonas MM. Children with hepatitis C. Hepatology. 2002;36(5 Suppl 1):S173–8. https://doi.org/10.1053/jhep.2002.36799.
-
(2002)
Hepatology
, vol.36
, pp. S173-S178
-
-
Jonas, M.M.1
-
21
-
-
40949103932
-
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C trial
-
PID: 18167062
-
Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C trial. Hepatology. 2008;47(3):836–43. https://doi.org/10.1002/hep.22094.
-
(2008)
Hepatology
, vol.47
, Issue.3
, pp. 836-843
-
-
Goodman, Z.D.1
Makhlouf, H.R.2
Liu, L.3
Balistreri, W.4
Gonzalez-Peralta, R.P.5
Haber, B.6
Jonas, M.M.7
Mohan, P.8
Molleston, J.P.9
Murray, K.F.10
Narkewicz, M.R.11
Rosenthal, P.12
Smith, L.J.13
Robuck, P.R.14
Schwarz, K.B.15
-
22
-
-
67650872979
-
Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C
-
PID: 19412012
-
Gonzalez-Peralta RP, Langham MR Jr, Andres JM, Mohan P, Colombani PM, Alford MK, et al. Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr. 2009;48(5):630–5. https://doi.org/10.1097/MPG.0b013e318170af04.
-
(2009)
J Pediatr Gastroenterol Nutr
, vol.48
, Issue.5
, pp. 630-635
-
-
Gonzalez-Peralta, R.P.1
Langham, M.R.2
Andres, J.M.3
Mohan, P.4
Colombani, P.M.5
Alford, M.K.6
-
23
-
-
27944447629
-
A significant sex—but not elective cesarean section—effect on mother-to-child transmission of hepatitis C virus infection
-
European Paediatric Hepatitis C Virus Network. A significant sex—but not elective cesarean section—effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis. 2005;192(11):1872–9. https://doi.org/10.1086/497695.
-
(2005)
J Infect Dis
, vol.192
, Issue.11
, pp. 1872-1879
-
-
-
24
-
-
0035056914
-
Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus
-
European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG. 2001;108(4):371–7.
-
(2001)
BJOG
, vol.108
, Issue.4
, pp. 371-377
-
-
-
25
-
-
0034626073
-
Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission
-
COI: 1:STN:280:DC%2BD3cvos1Cnug%3D%3D, PID: 11036896
-
Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet. 2000;356(9233):904–7.
-
(2000)
Lancet
, vol.356
, Issue.9233
, pp. 904-907
-
-
Gibb, D.M.1
Goodall, R.L.2
Dunn, D.T.3
Healy, M.4
Neave, P.5
Cafferkey, M.6
Butler, K.7
-
26
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
COI: 1:CAS:528:DC%2BD1MXpvFCrtbw%3D, PID: 19684573
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461(7262):399–401. https://doi.org/10.1038/nature08309.
-
(2009)
Nature
, vol.461
, Issue.7262
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
Urban, T.J.6
Heinzen, E.L.7
Qiu, P.8
Bertelsen, A.H.9
Muir, A.J.10
Sulkowski, M.11
McHutchison, J.G.12
Goldstein, D.B.13
-
27
-
-
79957467329
-
Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children
-
COI: 1:CAS:528:DC%2BC3MXmsFCqt78%3D, PID: 21413051
-
Ruiz-Extremera A, Munoz-Gamez JA, Salmeron-Ruiz MA, de Rueda PM, Quiles-Perez R, Gila-Medina A, et al. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology. 2011;53(6):1830–8. https://doi.org/10.1002/hep.24298.
-
(2011)
Hepatology
, vol.53
, Issue.6
, pp. 1830-1838
-
-
Ruiz-Extremera, A.1
Munoz-Gamez, J.A.2
Salmeron-Ruiz, M.A.3
de Rueda, P.M.4
Quiles-Perez, R.5
Gila-Medina, A.6
-
28
-
-
70349966196
-
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
-
COI: 1:CAS:528:DC%2BD1MXhtFentb%2FJ, PID: 19759533
-
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798–801. https://doi.org/10.1038/nature08463.
-
(2009)
Nature
, vol.461
, Issue.7265
, pp. 798-801
-
-
Thomas, D.L.1
Thio, C.L.2
Martin, M.P.3
Qi, Y.4
Ge, D.5
O'Huigin, C.6
-
29
-
-
85031914198
-
Spontaneous viral load decline and subsequent clearance of chronic hepatitis C virus in postpartum women correlates with favorable interleukin-28B gene allele
-
PID: 28903504
-
Hashem M, Jhaveri R, Saleh DA, Sharaf S, El-Mougy F, Abdelsalam L, et al. Spontaneous viral load decline and subsequent clearance of chronic hepatitis C virus in postpartum women correlates with favorable interleukin-28B gene allele. Clin Infect Dis. 2017;65(6):999–1005. https://doi.org/10.1093/cid/cix445.
-
(2017)
Clin Infect Dis
, vol.65
, Issue.6
, pp. 999-1005
-
-
Hashem, M.1
Jhaveri, R.2
Saleh, D.A.3
Sharaf, S.4
El-Mougy, F.5
Abdelsalam, L.6
-
30
-
-
17344365278
-
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome
-
COI: 1:STN:280:DyaK1czmtFWrsA%3D%3D, PID: 9697717
-
Dickover RE, Dillon M, Leung KM, Krogstad P, Plaeger S, Kwok S, et al. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis. 1998;178(2):375–87.
-
(1998)
J Infect Dis
, vol.178
, Issue.2
, pp. 375-387
-
-
Dickover, R.E.1
Dillon, M.2
Leung, K.M.3
Krogstad, P.4
Plaeger, S.5
Kwok, S.6
Christopherson, C.7
Deveikis, A.8
Keller, M.9
Stiehm, E.R.10
Bryson, Y.J.11
-
31
-
-
0028126996
-
Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County Pediatric AIDS Consortium and the Los Angeles County-University of Southern California Medical Center and the University of Southern California School of Medicine
-
COI: 1:STN:280:DyaK2M7pvFWiuw%3D%3D, PID: 7892076
-
Frederick T, Mascola L, Eller A, O'Neil L, Byers B. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County Pediatric AIDS Consortium and the Los Angeles County-University of Southern California Medical Center and the University of Southern California School of Medicine. Pediatr Infect Dis J. 1994;13(12):1091–7.
-
(1994)
Pediatr Infect Dis J
, vol.13
, Issue.12
, pp. 1091-1097
-
-
Frederick, T.1
Mascola, L.2
Eller, A.3
O'Neil, L.4
Byers, B.5
-
32
-
-
13144276295
-
Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the women and infants transmission study (WITS)
-
COI: 1:STN:280:DyaK1czivVCgtw%3D%3D, PID: 9665498
-
Diaz C, Hanson C, Cooper ER, Read JS, Watson J, Mendez HA, et al. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the women and infants transmission study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(3):221–8.
-
(1998)
J Acquir Immune Defic Syndr Hum Retrovirol
, vol.18
, Issue.3
, pp. 221-228
-
-
Diaz, C.1
Hanson, C.2
Cooper, E.R.3
Read, J.S.4
Watson, J.5
Mendez, H.A.6
Pitt, J.7
Rich, K.8
Smeriglio, V.9
Lew, J.F.10
-
33
-
-
0028003766
-
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group protocol 076 study group
-
COI: 1:STN:280:DyaK2M%2FitFGmuw%3D%3D, PID: 7935654
-
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group protocol 076 study group. N Engl J Med. 1994;331(18):1173–80. https://doi.org/10.1056/NEJM199411033311801.
-
(1994)
N Engl J Med
, vol.331
, Issue.18
, pp. 1173-1180
-
-
Connor, E.M.1
Sperling, R.S.2
Gelber, R.3
Kiselev, P.4
Scott, G.5
O'Sullivan, M.J.6
VanDyke, R.7
Bey, M.8
Shearer, W.9
Jacobson, R.L.10
Jimenez, E.11
O'Neill, E.12
Bazin, B.13
Delfraissy, J.F.14
Culnane, M.15
Coombs, R.16
Elkins, M.17
Moye, J.18
Stratton, P.19
Balsley, J.20
more..
-
34
-
-
33744479698
-
Reduction in perinatal transmission of HIV infection—United States, 1985–2005
-
Achievements in public health. Reduction in perinatal transmission of HIV infection—United States, 1985–2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592–7.
-
(2006)
MMWR Morb Mortal Wkly Rep
, vol.55
, Issue.21
, pp. 592-597
-
-
-
35
-
-
0016693477
-
Vertical transmission of hepatitis B antigen in Taiwan
-
COI: 1:STN:280:DyaE2M7gtVamsg%3D%3D, PID: 1113797
-
Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292(15):771–4. https://doi.org/10.1056/NEJM197504102921503.
-
(1975)
N Engl J Med
, vol.292
, Issue.15
, pp. 771-774
-
-
Stevens, C.E.1
Beasley, R.P.2
Tsui, J.3
Lee, W.C.4
-
36
-
-
0021086531
-
Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
-
COI: 1:STN:280:DyaL2c%2FjvVGgsQ%3D%3D, PID: 6138642
-
Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099–102.
-
(1983)
Lancet
, vol.2
, Issue.8359
, pp. 1099-1102
-
-
Beasley, R.P.1
Hwang, L.Y.2
Lee, G.C.3
Lan, C.C.4
Roan, C.H.5
Huang, F.Y.6
Chen, C.L.7
-
37
-
-
84929492457
-
Outcomes of infants born to women infected with hepatitis B
-
Schillie S, Walker T, Veselsky S, Crowley S, Dusek C, Lazaroff J, et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics. 2015;135(5):e1141–7. https://doi.org/10.1542/peds.2014-3213
-
(2015)
Pediatrics
, vol.135
, Issue.5
-
-
Schillie, S.1
Walker, T.2
Veselsky, S.3
Crowley, S.4
Dusek, C.5
Lazaroff, J.6
-
38
-
-
59149096271
-
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
-
PID: 19175878
-
Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16(2):94–103. https://doi.org/10.1111/j.1365-2893.2008.01056.x.
-
(2009)
J Viral Hepat
, vol.16
, Issue.2
, pp. 94-103
-
-
Xu, W.M.1
Cui, Y.T.2
Wang, L.3
Yang, H.4
Liang, Z.Q.5
Li, X.M.6
Zhang, S.L.7
Qiao, F.Y.8
Campbell, F.9
Chang, C.N.10
Gardner, S.11
Atkins, M.12
-
39
-
-
84891460915
-
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection
-
COI: 1:CAS:528:DC%2BC2cXntVaqs78%3D, PID: 24409065
-
Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol. 2013;19(48):9377–82. https://doi.org/10.3748/wjg.v19.i48.9377.
-
(2013)
World J Gastroenterol
, vol.19
, Issue.48
, pp. 9377-9382
-
-
Celen, M.K.1
Mert, D.2
Ay, M.3
Dal, T.4
Kaya, S.5
Yildirim, N.6
Gulsun, S.7
Barcin, T.8
Kalkanli, S.9
Dal, M.S.10
Ayaz, C.11
-
40
-
-
84974851752
-
Tenofovir to prevent hepatitis B transmission in mothers with high viral load
-
COI: 1:CAS:528:DC%2BC28XhvF2ksrjO, PID: 27305192
-
Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–34. https://doi.org/10.1056/NEJMoa1508660.
-
(2016)
China Study Group for the Mother-to-Child Transmission of Hepatitis,N Engl J Med
, vol.374
, Issue.24
, pp. 2324-2334
-
-
Pan, C.Q.1
Duan, Z.2
Dai, E.3
Zhang, S.4
Han, G.5
Wang, Y.6
Zhang, H.7
Zou, H.8
Zhu, B.9
Zhao, W.10
Jiang, H.11
-
41
-
-
84938213859
-
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
-
COI: 1:CAS:528:DC%2BC2MXht1KmsLzI, PID: 25851052
-
Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62(2):375–86. https://doi.org/10.1002/hep.27837.
-
(2015)
Hepatology
, vol.62
, Issue.2
, pp. 375-386
-
-
Chen, H.L.1
Lee, C.N.2
Chang, C.H.3
Ni, Y.H.4
Shyu, M.K.5
Chen, S.M.6
Hu, J.J.7
Lin, H.H.8
Zhao, L.L.9
Mu, S.C.10
Lai, M.W.11
Lee, C.L.12
Lin, H.M.13
Tsai, M.S.14
Hsu, J.J.15
Chen, D.S.16
Chan, K.A.17
Chang, M.H.18
-
42
-
-
84951825509
-
AASLD guidelines for treatment of chronic hepatitis B
-
PID: 26566064
-
Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–83. https://doi.org/10.1002/hep.28156.
-
(2016)
Hepatology
, vol.63
, Issue.1
, pp. 261-283
-
-
Terrault, N.A.1
Bzowej, N.H.2
Chang, K.M.3
Hwang, J.P.4
Jonas, M.M.5
Murad, M.H.6
-
43
-
-
84894621765
-
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
-
COI: 1:CAS:528:DC%2BC3sXhslehsr%2FN, PID: 24209977
-
Lawitz E, Poordad FF, Pang PS, Hyland RH, Ding X, Mo H, et al. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. Lancet. 2014;383(9916):515–23. https://doi.org/10.1016/S0140-6736(13)62121-2.
-
(2014)
Lancet
, vol.383
, Issue.9916
, pp. 515-523
-
-
Lawitz, E.1
Poordad, F.F.2
Pang, P.S.3
Hyland, R.H.4
Ding, X.5
Mo, H.6
Symonds, W.T.7
McHutchison, J.G.8
Membreno, F.E.9
-
44
-
-
84879012195
-
Perinatal outcomes of uninsured immigrant, refugee and migrant mothers and newborns living in Toronto, Canada
-
PID: 23727901
-
Wilson-Mitchell K, Rummens JA. Perinatal outcomes of uninsured immigrant, refugee and migrant mothers and newborns living in Toronto, Canada. Int J Environ Res Public Health. 2013;10(6):2198–213. https://doi.org/10.3390/ijerph10062198.
-
(2013)
Int J Environ Res Public Health
, vol.10
, Issue.6
, pp. 2198-2213
-
-
Wilson-Mitchell, K.1
Rummens, J.A.2
-
45
-
-
84894271181
-
Increasing access to prenatal care: disease prevention and sound business practice
-
PID: 23909293
-
Wilson-Mitchell K. Increasing access to prenatal care: disease prevention and sound business practice. Health Care Women Int. 2014;35(2):120–6. https://doi.org/10.1080/07399332.2013.810221.
-
(2014)
Health Care Women Int
, vol.35
, Issue.2
, pp. 120-126
-
-
Wilson-Mitchell, K.1
-
46
-
-
85020755386
-
Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014
-
PID: 28492929
-
Ly KN, Jiles RB, Teshale EH, Foster MA, Pesano RL, Holmberg SD. Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014. Ann Intern Med. 2017;166(11):775–82. https://doi.org/10.7326/M16-2350.
-
(2017)
Ann Intern Med
, vol.166
, Issue.11
, pp. 775-782
-
-
Ly, K.N.1
Jiles, R.B.2
Teshale, E.H.3
Foster, M.A.4
Pesano, R.L.5
Holmberg, S.D.6
-
47
-
-
84857144025
-
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007
-
PID: 22351712
-
Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271–8. https://doi.org/10.7326/0003-4819-156-4-201202210-00004.
-
(2012)
Ann Intern Med
, vol.156
, Issue.4
, pp. 271-278
-
-
Ly, K.N.1
Xing, J.2
Klevens, R.M.3
Jiles, R.B.4
Ward, J.W.5
Holmberg, S.D.6
-
48
-
-
84868203343
-
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C
-
COI: 1:CAS:528:DC%2BC38Xhs1ShtbrP, PID: 22619107
-
Aghemo A, Prati GM, Rumi MG, Soffredini R, D'Ambrosio R, Orsi E, et al. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. Hepatology. 2012;56(5):1681–7. https://doi.org/10.1002/hep.25867.
-
(2012)
Hepatology
, vol.56
, Issue.5
, pp. 1681-1687
-
-
Aghemo, A.1
Prati, G.M.2
Rumi, M.G.3
Soffredini, R.4
D'Ambrosio, R.5
Orsi, E.6
de Nicola, S.7
Degasperi, E.8
Grancini, V.9
Colombo, M.10
-
49
-
-
84900326091
-
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis
-
PID: 24720702
-
Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, et al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med. 2014;370(20):1879–88. https://doi.org/10.1056/NEJMoa1402355.
-
(2014)
N Engl J Med
, vol.370
, Issue.20
, pp. 1879-1888
-
-
Kowdley, K.V.1
Gordon, S.C.2
Reddy, K.R.3
Rossaro, L.4
Bernstein, D.E.5
Lawitz, E.6
Shiffman, M.L.7
Schiff, E.8
Ghalib, R.9
Ryan, M.10
Rustgi, V.11
Chojkier, M.12
Herring, R.13
di Bisceglie, A.M.14
Pockros, P.J.15
Subramanian, G.M.16
An, D.17
Svarovskaia, E.18
Hyland, R.H.19
Pang, P.S.20
Symonds, W.T.21
McHutchison, J.22
Muir, A.J.23
Pound, D.24
Fried, M.W.25
more..
-
50
-
-
84903795463
-
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis
-
PID: 24988388
-
Yehia BR, Schranz AJ, Umscheid CA, Lo Re V III. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One. 2014;9(7):e101554. https://doi.org/10.1371/journal.pone.0101554.
-
(2014)
PLoS One
, vol.9
, Issue.7
-
-
Yehia, B.R.1
Schranz, A.J.2
Umscheid, C.A.3
Lo Re, V.4
-
51
-
-
84964830360
-
Failure to test and identify perinatally infected children born to hepatitis C virus-infected women
-
PID: 26797211
-
Kuncio DE, Newbern EC, Johnson CC, Viner KM. Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clin Infect Dis. 2016;62(8):980–5. https://doi.org/10.1093/cid/ciw026.
-
(2016)
Clin Infect Dis
, vol.62
, Issue.8
, pp. 980-985
-
-
Kuncio, D.E.1
Newbern, E.C.2
Johnson, C.C.3
Viner, K.M.4
-
52
-
-
75149163334
-
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression
-
PID: 19861128, 21 e1–6
-
Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138(2):513–21, 21 e1–6. https://doi.org/10.1053/j.gastro.2009.09.067.
-
(2010)
Gastroenterology
, vol.138
, Issue.2
, pp. 513-521
-
-
Davis, G.L.1
Alter, M.J.2
El-Serag, H.3
Poynard, T.4
Jennings, L.W.5
-
53
-
-
84894609186
-
Impact of birth cohort screening for hepatitis C
-
PID: 24595618
-
Asrani SK, Davis GL. Impact of birth cohort screening for hepatitis C. Curr Gastroenterol Rep. 2014;16(4):381. https://doi.org/10.1007/s11894-014-0381-5.
-
(2014)
Curr Gastroenterol Rep
, vol.16
, Issue.4
, pp. 381
-
-
Asrani, S.K.1
Davis, G.L.2
-
54
-
-
84864287057
-
Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues
-
COI: 1:CAS:528:DC%2BC38Xns1Sjs7c%3D, PID: 22484494
-
Bonner JE, Barritt AS 4th, Fried MW, Evon DM. Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues. Dig Dis Sci. 2012;57(6):1469–74. https://doi.org/10.1007/s10620-012-2141-4.
-
(2012)
Dig Dis Sci
, vol.57
, Issue.6
, pp. 1469-1474
-
-
Bonner, J.E.1
Barritt, A.S.2
Fried, M.W.3
Evon, D.M.4
-
55
-
-
84954509484
-
Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population
-
PID: 26595724
-
Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, et al. Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population. JAMA Intern Med. 2016;176(1):65–73. https://doi.org/10.1001/jamainternmed.2015.6011.
-
(2016)
JAMA Intern Med
, vol.176
, Issue.1
, pp. 65-73
-
-
Chahal, H.S.1
Marseille, E.A.2
Tice, J.A.3
Pearson, S.D.4
Ollendorf, D.A.5
Fox, R.K.6
Kahn, J.G.7
-
56
-
-
84998772526
-
Value of treating all stages of chronic hepatitis C: a comprehensive review of clinical and economic evidence
-
PID: 27783223
-
Nuno Solinis R, Arratibel Ugarte P, Rojo A, Sanchez Gonzalez Y. Value of treating all stages of chronic hepatitis C: a comprehensive review of clinical and economic evidence. Infect Dis Ther. 2016;5(4):491–508. https://doi.org/10.1007/s40121-016-0134-x.
-
(2016)
Infect Dis Ther
, vol.5
, Issue.4
, pp. 491-508
-
-
Nuno Solinis, R.1
Arratibel Ugarte, P.2
Rojo, A.3
Sanchez Gonzalez, Y.4
-
57
-
-
84856239637
-
All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective
-
PID: 21870894
-
McAdam-Marx C, McGarry LJ, Hane CA, Biskupiak J, Deniz B, Brixner DI. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. J Manag Care Pharm. 2011;17(7):531–46. https://doi.org/10.18553/jmcp.2011.17.7.531.
-
(2011)
J Manag Care Pharm
, vol.17
, Issue.7
, pp. 531-546
-
-
McAdam-Marx, C.1
McGarry, L.J.2
Hane, C.A.3
Biskupiak, J.4
Deniz, B.5
Brixner, D.I.6
-
58
-
-
84868212975
-
Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection
-
PID: 22610658
-
Gordon SC, Pockros PJ, Terrault NA, Hoop RS, Buikema A, Nerenz D, et al. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology. 2012;56(5):1651–60. https://doi.org/10.1002/hep.25842.
-
(2012)
Hepatology
, vol.56
, Issue.5
, pp. 1651-1660
-
-
Gordon, S.C.1
Pockros, P.J.2
Terrault, N.A.3
Hoop, R.S.4
Buikema, A.5
Nerenz, D.6
Hamzeh, F.M.7
-
59
-
-
84896490595
-
Sticker shock and the price of new therapies for hepatitis C: is it worth it?
-
PID: 24493069
-
Reau NS, Jensen DM. Sticker shock and the price of new therapies for hepatitis C: is it worth it? Hepatology. 2014;59(4):1246–9. https://doi.org/10.1002/hep.27039.
-
(2014)
Hepatology
, vol.59
, Issue.4
, pp. 1246-1249
-
-
Reau, N.S.1
Jensen, D.M.2
|